July 20, 2007 – At its recent venture capital conference, Zero2IPO recognized the accomplishments of several early-stage Chinese life science companies, naming 3 life science companies to the Venture 50, its ranking of the most suitable enterprises for investment. It also gave its top biotech award to Sino-Swed TongKang Biological Technology. In addition, we detail the participation of life science companies in the second quarter early investment activity that Zero2IPO released at the conference. More details...
